What is AVGO's health score?

Broadcom Inc. (AVGO) has a TradeApes health score of 63 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AVGO's estimated fair value?

Based on our 5-year discounted cash flow model, Broadcom Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is AVGO undervalued or overvalued?

Our model currently rates AVGO as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for AVGO... Refresh in a moment for the full analysis.

Broadcom Inc. (AVGO)

Technology Overvalued low healthy

$385.73

Updated: 2026-06-06

TradeApes Score

Financial Strength

75 Strong

Operating Trend

88 Strong

Relative Value

38 Weak

Capital Allocation

40 Weak

Risk

70 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.